Failure of SC-19220 to affect prostaglandin E1 (PGR1) gastric antisecretory actions.
D000818:Animals; D003864:Depression, Chemical; D003989:Dibenzoxazepines / Q000494:pharmacology*; D005750:Gastric Juice / Q000187:drug effects* / Q000378:metabolism; D006834:Hydrazines / Q000008:administration & dosage / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008026:Ligation; D008297:Male; D010082:Oxepins / Q000008:administration & dosage / Q000494:pharmacology*; D010434:Pepsin A / Q000378:metabolism; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000494:pharmacology*; D011708:Pylorus; D051381:Rats; D013268:Stimulation, Chemical
D003989:Dibenzoxazepines; D006834:Hydrazines; D010082:Oxepins; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D010434:Pepsin A